|
General Information
|
|
|
Product
|
cIAP2 Peptide
|
|
Description
|
Antigenic Blocking Peptide baculoviral IAP repeat-containing protein 2 isoform 1 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic Peptide
|
|
Accession #
|
NCBI: NP_001157.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
|
Uniprot #
|
Q134990
|
|
Subcellular Location
|
Cytoplasm; Nucleus
|
|
Expression
|
Is present in fetal and adult tissues and is mostly expressed in adult skeletal muscle, thymus, testis, ovary, and pancras. Is low or absent in both brain and peripheral blood leukocytes.
|
|
Structure
|
Interacts with DIABLO/SMAC. Interacts with CASP9. Interacts with TRAF2; intercation required for IKBE ubiquination.
|
|
Alternative Nomenclature
|
AIP 1 antibody
API 2 antibody
Apoptosis inhibitor 2 antibody
Baculoviral IAP repeat containing 3 antibody
BIRC 3 antibody
HAIP 1 antibody
HIAP1 antibody
IAP homolog C antibody
MALT 2 antibody
Mammalian IAP homolog C antibody
MIHC antibody
RING finger protein 49 antibody
RNF49 antibody
TNFR2 TRAF signaling complex protein 1 antibody
|
cIAP2 Antibody
cIAP2 Antibody FITC
cIAP2 Antibody BIOTIN
cIAP2 Positive Control
